Human papillomavirus-16 is integrated in lung carcinomas: A study in Chile

British Journal of Cancer

Volumn 97, Issue 1, 2007, Pages 85-91

  Aguayo, F ^a   Castillo, A ^a   Koriyama, C ^a   Higashi, M ^a   Itoh, T ^b   Capetillo, M ^c   Shuyama, K ^a   Corvalan, A ^d   Eizuru, Y ^a   Akiba, S ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Ijuin Hospital   (Japan)

^c HOSPITAL DEL SALVADOR   (Chile)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Chile; Human papillomavirus; Integration; Lung carcinoma; Viral load

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CHILE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; INFECTION RISK; LUNG CARCINOGENESIS; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; SQUAMOUS CELL CARCINOMA; VIRUS DETECTION; VIRUS LOAD;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; CHILE; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD; VIRUS INTEGRATION;

EID: 34347352186     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603848     Document Type: Article

References (47)

1. Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM (2006) Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 44: 1755-1762
2. Aubin F, Humbey O, Guerrini JS, Mougin C, Laurent R (2003) Non-melanoma skin cancers and human papillomavirus. Ann Dermatol Venereol 130: 1131-1138
3. Barbosa MS (1996) The oncogenic role of human papillomavirus proteins. Crit Rev Oncog 7: 1-18
4. Ben-Ezra J, Johnson J, Rossi N, Cook N, Wu A (1991) Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction. J Histochem Cytochem 39: 351-354
5. Bohlmeyer T, Le TN, Shroyer L, Markam N, Shryoer KR (1998) Detection of human papillomavirus in squamous celll carcinoma of lung by polymerase chain reaction. Am J Respir Cell Mol Biol 18: 265-269
6. Bosch FX, Lorincz A, Munoz N, Meijer C, Shah KV (2002) The causal relationship between human papillomavirus and cervical cancer. J Clin Pathol 55: 244-265
7. Castellsague X, Diaz M, de Sanjose S, Munoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ, Meijer CJ, Bosch FX (2006) International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 98: 303-315
8. Castillo A, Aguayo F, Koriyama C, Shuyama K, Akiba S, Herrera-Goepfert R, Carrascal E, Klinge G, Sanchez J, Eizuru Y (2006) Human papillomavirus in lung carcinomas among three Latin American countries. Oncol Rep 15: 883-888
9. Chen YC, Chen JH, Richard K, Chen PY, Christiani DC (2004) Lung adenocarcinoma and human papillomavirus infection. Cancer 101: 1428-1436
10. Cheng YL, Lee SC, Harn HJ, Chen CJ, Chang YC, Chen JC, Yu CP (2003) Prognostic prediction of the immunohistochemical expression of p53 and p16 in resected non-small cell lung cancer. Eur J Cardiothorac Surg 23: 221-228
11. Cheng YW, Chiou HL, Sheu GT, Hsieh LL, Chen JT, Chen CY, Su JM, Lee H (2001) The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res 61: 2799-2803
12. Chiou HL, Wu MF, Liaw YC, Cheng YW, Wong RH, Chen CY, Lee H (2003) The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker. Cancer 97: 1558-1563
13. Coissard CJ, Besson G, Polette MC, Monteau M, Birembaut PL, Clavel CE (2005) Prevalence of human papillomaviruses in lung carcinomas: a study of 218 cases. Mod Pathol 18: 1606-1609
14. De Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ (1995) The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76: 1057-1062
15. Fei Y, Yang J, Hsieh WC, Wu JY, Wu TC, Goan YG, Lee H, Cheng YW (2006) Different human papillomavirus 16/18 infection in Chinese non-small cell lung cancer patients living in Wuhan, China. Jpn J Clin Oncol 36: 274-279
16. Geradts J, Fong KM, Zimmerman PV, Maynard R, Minna JD (1999) Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers. Clin Cancer Res 5: 791-800
17. Ho CM, Chien TY, Huang SH, Lee BH, Chang SF (2006) Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer. Gynecol Oncol 102: 54-60
18. Hoppe-Seyler F, Butz K (1994) Cellular control of human papillomavirus oncogene transcription. Mol Carcinog 10: 134-141
19. Howley PM, Lowy DR (2001) Papillomavirus and their replication. In: Knipe DM, Howley PM (eds). Fields Virology. Tokyo: Lipppincott Williams & Wilkins. pp 2197-2229
20. Hudelist G, Manavi M, Pischinger KI, Watkins-Riedel T, Singer CF, Kubista E, Czerwenka KF (2004) Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol Oncol 92: 873-880
21. Ishikawa M, Fujii T, Saito M, Nindl I, Ono A, Kubushiro K, Tsukazaki K, Mukai M, Nozawa S (2006) Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia. Int J Gynecol Cancer 16: 347-353
22. Iwasaka T, Hayashi Y, Yokoyama M, Hara K, Matsuo N, Sugimori H (1992) 'Hit and run' oncogenesis by human papillomavirus type 18 DNA. Acta Obstet Gynecol Scand 71: 219-223
23. Jeon S, Lambert PF (1995) Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci USA 92: 1654-1658
24. Karlsen F, Kalantari M, Chitemerere M, Johansson B, Hagmar B (1994) Modifications of human and viral deoxyribonucleic acid by formaldehyde fixation. Lab Invest 71: 604-611
25. Khleif SN, DeGregori J, Yee C, Otterson GA, Kaye FJ, Nevins JR, Howley PM (1996) Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci USA 93: 4350-4354
26. Kinjo T, Kamiyama K, Chinen K, Iwamasa T, Kurihara T, Hamada T (2003) Squamous metaplasia induced by transfection of human papillomavirus DNA into cultured adenocarcinoma cells. Mol Pathol 56: 97-108
27. Koriyama C, Kitajima S, Nomoto M, Sueyoshi K, Itoh T, Eizuru Y, Yonezawa S, Akiba S (2004) Loss of p16/CDKN2A protein in Epstein-Barr virus-associated gastric carcinoma. Oncology 67: 81-87
28. Koskinen WJ, Chen RW, Leivo I, Makitie A, Back L, Kontio R, Suuronen R, Lindqvist C, Auvinen E, Molijn A, Quint WG, Vaheri A, Aaltonen LM (2003) Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer 107: 401-416
29. McBride A, Romanczuk H, Howley P (1991) The papillomavirus E2 regulatory proteins. J Biol Chem 266: 18411-18414
30. Mincheva A, Gissmann L, zur Hausen H (1987) Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization. Med Microbiol Immunol (Berl) 176: 245-256
31. Miyagi J, Tsuhako K, Kinjo T, Iwamasa T, Hirayasu T (2000) Recent striking changes in histological differentiation and rate of human papillomavirus infection in squamous cell carcinoma of the lung in Okinawa, a subtropical island in southern Japan. J Clin Pathol 53: 676-684
32. Papadopoulou K, Labropoulou V, Davaris P, Mavromara P, Tsimara-Papastamatiou H (1998) Detection of human papillomaviruses in squamous cell carcinomas of the lung. Virchows Arch 433: 49-54
33. Peitsaro P, Johansson B, Syrjanen S (2002) Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative realtime PCR technique. J Clin Microbiol 40: 886-891
34. Sanchez-Cespedes M (2003) Dissecting the genetic alterations involved in lung carcinogenesis. Lung Cancer 40: 111-121
35. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T (1998) Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 153: 1741-1748
36. Scheffner M, Weness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes degradation of p53. Cell 63: 1129-1136
37. Schorge JO, Lea JS, Elias KJ, Rajanbabu R, Coleman RL, Miller DS, Ashfaq R (2004) P16 as a molecular biomarker of cervical adenocarcinoma. Am J Obstet Gynecol 190: 668-673
38. Si HX, Tsao SW, Poon CS, Wong YC, Cheung AL (2005) Physical status of HPV-16 in esophageal squamous cell carcinoma. J Clin Virol 32: 19-23
39. Smith EM, Ritchie JM, Summersgill KF, Klussmann JP, Lee JH, Wang D, Haugen TH, Turek LP (2004) Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 108: 766-772
40. Soini Y, Kamel KN, Pollanen R, Vahakangas K, Lehto V, Paako P (1996) Presence of human papillomavirus DNA and abnormal p53 protein accumulation in lung carcinoma. Thorax 51: 887-893
41. Syrjänen KJ (2002) HPV infections and lung cancer. J Clin Pathol 55: 885-891
42. Tammemagi MC, McLaughlin JR, Bull SB (1999) Meta-analyses of p53 tumor suppressor gene alterations and clinicopathological features in resected lung cancers. Cancer Epidemiol Biomarkers Prev 8: 625-634
43. The Japan Lung Cancer Society (2000) Classification of Lung Cancer, 1st edn. Tokyo: Kanehara & Co, Ltd, pp 54-65
44. Toyooka S, Tsuda T, Gazdar AF (2003) The TP53 gene, tobacco exposure, and lung cancer. Hum Mutat 21: 229-239
45. Weber W, De Sabata MS, Paredes RM, Rodriguez G, Santos C, Sabillon JU, Zwahlen M (2005) Cancer in first degree relatives of Latin American women with cervical cancer: a pilot study. Anticancer Res 25: 1219-1223
46. World Health Organization (1982) The World Health Organization histological typing of lung tumors. Am J Clin Pathol 77: 123-136
47. Zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev 2: 342-350